Clinical Trial Update: Lymph Node Pathologic Grading Strategy

View source ↗

Summary

The document reports a clinical trial by Fudan University investigating a lymph node pathologic grading strategy for lung adenocarcinoma, with status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Fudan University | Conditions: Lung Adenocarcinoma | Status: RECRUITING